# PLAB earnings call intelligence LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/PLAB) · [Earnings tab](https://www.lopjlb.com/stock/PLAB?tab=earnings) Updated: 2026-08-26T07:19:11 Quarters analyzed: 8 ## Cross-quarter narrative Across eight quarters, Photronics has navigated persistent demand opacity — backlogs consistently 1–3 weeks — while shifting from broad macro uncertainty to specific geopolitical, tariff, and technology-driven headwinds. High‑end IC demand showed strength through 2024–25 (record revenue in Q1 FY26) but stalled in Q2 FY26 as foundry customers delayed design releases amid elevated fab utilization, memory constraints, and geopolitical tension. Mainstream mask weakness, especially in Asia, has deepened, with competitive pressure from Chinese makers intensifying. The company accelerated a multi‑year capacity buildout in the US (Texas, Idaho, Allen, Boise) and Korea targeting 6–8nm and advanced packaging, lifting CapEx from $130M to $330M. Gen 8.6 OLED and multi‑beam mask writer milestones progressed, though end‑of‑life tool replacement slipped and equipment qualification risks emerged. Margins held at the high end but remain mix‑sensitive. Shareholder returns expanded via a $100M buyback increase and $72M executed. CHIPS Act funding stayed at risk. Seasonal Chinese New Year effects recurred. Overall, the narrative is one of strategic investment amid cyclical and structural demand fog. ## Latest CallCard · Q2 PLAB Q2 revenue flat at $210M; IC down 5% on delayed design releases from high fab utilization, memory constraints, geopolitics; US/Korea expansions on track for late FY26/27 revenue; Q3 guide $207-215M. **Guidance:** maintained — Q3 revenue guided $207-215M, operating margin 18-20%, non-GAAP EPS $0.39-0.45; FY2026 CapEx maintained at $330M; visibility limited with 1-3 week backlog. **Tone:** mgmt 0.2 · Q&A pressure 0.5 · divergence 0.3 Management acknowledges near-term headwinds but emphasizes strong long-term AI demand, on-track strategic expansions, and FPD strength. ### Demand visibility Limited near-term visibility; design releases delayed by high fab utilization, memory constraints, geopolitics; some recovery early Q3. Design releases slowed due to: 1) elevated fab utilization limiting capacity for new designs, 2) chip OEMs prioritizing existing products, 3) memory price surge/supply constraints delaying consumer electronics launches, 4) geopolitical developments (US-Iran conflict). Slowdown after Chinese New Year (end Feb) longer than anticipated. Some tape-out recovery seen beginning of May (start of Q3). ### Margins / costs Gross margin 31%, operating margin 20% in Q2; limited cost levers due to fixed cost structure; margins driven by product mix and utilization. Eric Rivera stated 'very little levers we can pull' as most costs are fixed. Margin dependent on product mix the market provides. High-end masks carry significantly higher ASPs, so even small order changes materially impact revenue and earnings. ### Capital allocation Cash $638M; priorities: reinvestment, strategic opportunities, shareholder returns; CapEx $330M FY26 focused on US/Korea expansions. Capital allocation strategy remains focused on three priorities: reinvestment in business for organic growth, pursuing strategic opportunities, and returning capital to shareholders. Evaluating additional investment opportunities beyond current $330M CapEx plan. $477M cash held in JVs (50.01% ownership). Operating cash flow $47M (22% of revenue). ### Milestones - **Korea expansion to 8nm and below** [on_track]: Cleanroom preparation underway; key equipment installations expected to begin later in fiscal year. - **Allen, Texas expansion** [on_track]: Qualification masks production started in Q3; initial revenue targeted late fiscal 2026; meaningful contribution expected 2027+. - **Boise facility advanced nodes** [on_track]: Qualified for 7nm production; working with customers on even more advanced nodes. - **FPD G8.6 AMOLED mask writer** [delivered]: Recently installed tool entering production; expected to maximize opportunity in higher ASP G8.6 AMOLED layers. - **Taiwan and US advanced packaging** [on_track]: Well positioned to capture increasing opportunities in advanced chip packaging applications. - **Potential additional strategic investments** [new]: Evaluating additional investment opportunities to support long-term growth objectives; will provide details if decisions made. ### Fears / risks - **Geopolitical uncertainty**: US-Iran conflict increased macroeconomic uncertainty, contributing to delayed design releases. - **Elevated fab utilization**: Higher-than-normal fab utilization rates limiting capacity for additional design releases from foundry customers. - **Memory supply constraints**: Memory price surge and supply constraints delaying consumer electronics launches, particularly low-end products in Asia (Taiwan, China). - **OEM prioritization of existing products**: Chip OEMs prioritizing revenue/profitability from existing products, continuing wafer production on current designs while delaying new releases. - **Limited near-term visibility**: Typical backlog only 1-3 weeks; high-end mask ASP variability means small order changes materially impact revenue and earnings. - **Fixed cost structure margin risk**: Most costs are fixed; very few variable cost levers available if demand stays soft, making margins dependent on utilization and product mix. - **Allen expansion in weak demand**: Risk that bringing new Allen capacity online into weak demand environment adds depreciation costs, though management expects returns not depressed. - **Design release timing uncertainty**: Customers optimistic mid-term but near-term visibility remains limited; tape-out delays observed in Q2 with only partial recovery early Q3. ### Key quotes > “Industry demand for leading-edge memory and logic chips for AI applications remains exceptionally strong.” > “Given current market conditions and the influence of elevated AI demand on fab utilization and therefore, design starts, we expect fiscal Q3 revenue to be in the range of $207 million to $215 million.” > “Yes, very little levers we can pull. I mean it's really the product mix that will be available that the market gives us is what we'll have. Most of our cost is fixed or a big portion of it anyway is very fixed.” — Eric Rivera > “Our Allen expansion is not only capacity expansion. We upgrade our technology. So the qualification basically is for the technology, which Allen cannot do at this moment.” — KangJyh Lee > “In terms of our aspirations to go 8-nanometer, 7-nanometer, we're going to continue going down node. I mean we have to do that because that's the -- that's our industry.” — Eric Rivera ## Quarter one-liners - **2026 Q2:** PLAB Q2 revenue flat at $210M; IC down 5% on delayed design releases from high fab utilization, memory constraints, geopolitics; US/Korea expansions on track for late FY26/27 revenue; Q3 guide $207-215M. - **2026 Q1:** Photronics Q1 FY2026 revenue rose 4% to $225M with strong high‑end IC growth, 35% gross margin and elevated CapEx, while guidance for Q2 is modestly lower amid seasonal Chinese New Year impact. - **2025 Q4:** — - **2025 Q3:** Photronics posted a solid Q3 with $210M revenue, beat EPS guidance, and announced U.S. capacity expansions while noting limited demand visibility and geopolitical headwinds. - **2025 Q2:** Photronics posted flat Q2 revenue, margins above guidance, highlighted US capacity expansion and node‑migration opportunities, but flagged mainstream weakness, tariff uncertainty and limited demand visibility. - **2025 Q1:** Photronics posted $212 M Q1 revenue, EPS above guidance, but sees flat Q2 outlook amid weak low‑end mainstream demand, rising competition and macro/geopolitical uncertainty. - **2024 Q4:** Photronics posted a strong Q4 with sales above guidance, highlighted robust high‑end IC demand, and outlined a $200M 2025 CapEx plan focused on US capacity expansion. - **2024 Q3:** Q3 sales fell short of expectations on soft Asian demand, margins slipped modestly, cash remains strong and the company raised its share buyback while staying optimistic on long‑term megatrends despite macro uncertainty. ## Theme arcs - **Demand visibility** (stable): Backlog consistently 1–3 weeks across all quarters; forecasting remains challenged. - **High‑end IC demand** (deteriorating): Strong through 2025 but design releases delayed in Q2 FY26 due to fab utilization, memory supply, geopolitics. - **Mainstream/low‑end demand** (deteriorating): Broad‑based weakness persisted, with 12% YoY decline noted in Q3 2025 and continued softness in Q2 FY26. - **US/Korea capacity expansion** (improving) ## Guidance path 2024 Q3:maintained → 2024 Q4:maintained → 2025 Q1:maintained → 2025 Q2:maintained → 2025 Q3:maintained → 2025 Q4:vague → 2026 Q1:maintained → 2026 Q2:maintained --- Research context only. Not personalized investment advice. API: `GET /bff/api/bigfive/earnings-intel/PLAB`